Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

May 1, 2024

https://www.globenewswire.com/news-release/2024/05/01/2873660/0/en/Belite-Bio-Announces-Presentation-at-the-Association-for-Research-in-Vision-and-Ophthalmology-2024-Annual-Meeting.html

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ:BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced the presentation at Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2024) being held May 5 – 9, 2024, in Seattle, WA.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.